Research Focus

Graduate Staff; NE Rotating Housestaff

Recent additions – View all

1. A phase 1b study with selinexor, a first in class selective inhibitor of nuclear export (SINE) in patients with advanced sarcomas: An efficacy analysis

   Meeting Abstract

   Gounder, M. M.; Zer, A.; Tap, W. D.; Gupta, A. A.; Keohan, M. L.; Dickson, M. A.; D'Angelo, S. P.; Chi, P.; Tanner, L. R.; Konen, T.; more...
   Journal of Clinical Oncology (2015)

   Fulltext@MSK | Save
2. Phase 1/2 dose escalation trial of the prostate-specific membrane antigen (PSMA)targeted immunoconjugate MLN2704 in patients with progressive metastatic castration-resistant prostate cancer (CRPC)

   Meeting Abstract

   Milowsky, M. I.; Galsky, M.; Lewin, J.; Rozario, C. P.; Owens, L.; Marshall, T.; Nanus, D.; Webb, I. J.; Scher, H. I.
   Journal of Clinical Oncology (2005)

   Fulltext@MSK | Save